Anti-FLRT2 monoclonal antibody

Anti-FLRT2 antibody for FACS & in-vivo assay

Target products collectionGo to FLRT2/FLRT2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0444-Ab-1/ GM-Tg-hg-MP0444-Ab-2Anti-Human FLRT2 monoclonal antibodyHuman
GM-Tg-rg-MP0444-Ab-1/ GM-Tg-rg-MP0444-Ab-2Anti-Rat FLRT2 monoclonal antibodyRat
GM-Tg-mg-MP0444-Ab-1/ GM-Tg-mg-MP0444-Ab-2Anti-Mouse FLRT2 monoclonal antibodyMouse
GM-Tg-cynog-MP0444-Ab-1/ GM-Tg-cynog-MP0444-Ab-2Anti-Cynomolgus/ Rhesus macaque FLRT2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0444-Ab-1/ GM-Tg-felg-MP0444-Ab-2Anti-Feline FLRT2 monoclonal antibodyFeline
GM-Tg-cang-MP0444-Ab-1/ GM-Tg-cang-MP0444-Ab-2Anti-Canine FLRT2 monoclonal antibodyCanine
GM-Tg-bovg-MP0444-Ab-1/ GM-Tg-bovg-MP0444-Ab-2Anti-Bovine FLRT2 monoclonal antibodyBovine
GM-Tg-equg-MP0444-Ab-1/ GM-Tg-equg-MP0444-Ab-2Anti-Equine FLRT2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0444-Ab-1/ GM-Tg-hg-MP0444-Ab-2; GM-Tg-rg-MP0444-Ab-1/ GM-Tg-rg-MP0444-Ab-2;
GM-Tg-mg-MP0444-Ab-1/ GM-Tg-mg-MP0444-Ab-2; GM-Tg-cynog-MP0444-Ab-1/ GM-Tg-cynog-MP0444-Ab-2;
GM-Tg-felg-MP0444-Ab-1/ GM-Tg-felg-MP0444-Ab-2; GM-Tg-cang-MP0444-Ab-1/ GM-Tg-cang-MP0444-Ab-2;
GM-Tg-bovg-MP0444-Ab-1/ GM-Tg-bovg-MP0444-Ab-2; GM-Tg-equg-MP0444-Ab-1/ GM-Tg-equg-MP0444-Ab-2
Products NameAnti-FLRT2 monoclonal antibody
Formatmab
Target NameFLRT2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FLRT2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species FLRT2 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm003049mouse Flrt2 Lentivirus plasmid
    ORF Viral VectorvGMLPm003049mouse Flrt2 Lentivirus particle


    Target information

    Target IDGM-MP0444
    Target NameFLRT2
    Gene ID23768,399558,299236,709329,490820,101090446,539905,100052762
    Gene Symbol and SynonymsFLRT2
    Uniprot AccessionO43155,D3ZTV3
    Uniprot Entry NameFLRT2_HUMAN,FLRT2_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000185070
    Target ClassificationN/A

    The target: FLRT2, gene name: FLRT2, also named as . This gene encodes a member of the fibronectin leucine rich transmembrane (FLRT) family of cell adhesion molecules, which regulate early embryonic vascular and neural development. The encoded type I transmembrane protein has an extracellular region consisting of an N-terminal leucine-rich repeat domain and a type 3 fibronectin domain, followed by a transmembrane domain and a short C-terminal cytoplasmic tail domain. It functions as both a homophilic cell adhesion molecule and a heterophilic chemorepellent through its interaction with members of the uncoordinated-5 receptor family. Proteolytic removal of the extracellular region controls the migration of neurons in the developing cortex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.